This technology enables us to detect possible alterations in the embryos before the embryo transfer. It is a great help in certain determined conditions.
The DPG is the analysis of chromosome and genetic alterations in the embryo before its transfer to the mother. It enables us to find embryos without any chromosome or genetic mutation defects.
The objective of this analysis is to guaranty a safe transfer. To perform the DGP, it is necessary to perform an In Vitro Fertilization treatment with ICSI or IMSI. Three days after the micro-injection, the embryos have 6-8 cells. We sample one cell on each of them, and we analyze it by molecular biological techniques to put aside the embryos presenting any genetic defect.
This technique is recommended in the following cases:
- Autosomal hereditary diseases or diseases related to sexual chromosomes such as: Huntington’s disease, fragile X syndrome, Myotonic dystrophy, Marfan Syndrome, Retinoschisis, Hemophilia A, Cystic fibrosis, Beta-thalassemia, Duchenne muscular dystrophy, Polycystic kidney disease and others.
- Structural chromosome alterations, such as translocations or inversions.
- Repeated abortions. In 50% of cases, the cause resides in the embryo and not in the couple. The DGP, with the help of the FISH technique is used to select the embryos free of defect (analysis of 9 chromosomes: X, Y, 13, 15, 16, 17, 18, 21 and 22), which increases the chances of a successful pregnancy.
- Failures prior to the FIV. The embryos may show a normal external aspect, even if they contain genetic alterations that may prevent the implantation and ensure the success of the treatment. The DGP is used to select a more accurate embryo.
- Advanced age of the mother.
- Male factor: alterations revealed by the FISH analysis, meiosis, DNA fragmentation.